NUTRITIONAL AND HORMONAL REGULATION OF HEPATIC GENES
Project Number5R01DK026919-15
Contact PI/Project LeaderTOWLE, HOWARD C
Awardee OrganizationUNIVERSITY OF MINNESOTA
Description
Abstract Text
The liver is the primary organ dealing with ingested carbohydrates in
mammals and, as such, t is responsible for converting excess dietary
carbohydrates to triglycerides. Increased intake of carbohydrate leads t
increased hepatic lipogenesis and this process is regulated in part by
changes in the production of enzymes involved in the formation of
triglycerides. Little is currently known regarding the mechanisms by
which nutritional factors control gene expression in mammalian systems
and the long range goal of this research is to explore this pathway.
For this purpose, we are focusing on the expression of two hepatic genes
- pyruvate kinase and the S14 gene. The rates of transcription of both
of these genes respond rapidly and markedly to carbohydrate feeding.
These changes can be mimicked in cultured primary hepatocytes which
allows us to identify DNA sequences critical for the regulation of gene
expression by carbohydrate. For both S14 and pyruvate kinase, DNA
sequences from the 5'-flanking region were shown to be capable of
conferring glucose- activation to a linked reporter gene. We hypothesize
that a common carbohydrate-responsive transcription factor is binding to
sites in the 5'-flanking region of these genes. Or goal is to identify
and characterize the cis-acting DNA sequences and trans-acting factor(s)
responsible for controlling this process. This will be accomplished by
(1) using mutagenesis techniques, essential DNA sequences for the
carbohydrate response of the pyruvate kinase and S14 genes will be
defined in transfected hepatocytes and transgenic mice; (2) identifying
the hepatic carbohydrate-responsive factor(s) which interacts with these
DNA sequences; and (3) purifying and cloning of the carbohydrate-
responsive factor from liver. This clone will provide a critical tool
for further studies to explore the signalling pathway by which the
hepatocyte can 'sense' increased glycolysis and respond by changing
specific gene expression. In modern man with the ready availability of
simple sugars in the diet, this pathway and its control could be a
factor leading to excess conversion to triglycerides and problems
associated with obesity.
The expression of the S14 gene is also regulated in response to thyroid
hormone. The two stimuli control S14 gene expression in a synergistic
manner. Recent evidence from the laboratory suggests an interaction
between the T3 receptor and components of the carbohydrate pathway.
Using CDNA clones to the T3 receptor obtained in the previous funding
period, we will test various models for the interaction of the receptor
and the carbohydrate-responsive factor. These studies should provide
insight into the mechanism by which two distinct stimuli can act to
coordinately control gene expression.
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
DUNS Number
555917996
UEI
KABJZBBJ4B54
Project Start Date
01-April-1980
Project End Date
30-November-1996
Budget Start Date
01-December-1994
Budget End Date
30-November-1995
Project Funding Information for 1995
Total Funding
$168,758
Direct Costs
$119,677
Indirect Costs
$49,081
Year
Funding IC
FY Total Cost by IC
1995
National Institute of Diabetes and Digestive and Kidney Diseases
$168,758
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01DK026919-15
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01DK026919-15
Patents
No Patents information available for 5R01DK026919-15
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01DK026919-15
Clinical Studies
No Clinical Studies information available for 5R01DK026919-15
News and More
Related News Releases
No news release information available for 5R01DK026919-15
History
No Historical information available for 5R01DK026919-15
Similar Projects
No Similar Projects information available for 5R01DK026919-15